Cardiotoxicity of Contemporary Anticancer Immunotherapy
Sign Up to like & getrecommendations! Published in 2020 at "Current Treatment Options in Cardiovascular Medicine"
DOI: 10.1007/s11936-020-00867-1
Abstract: Contemporary anticancer immunotherapy, particularly immune checkpoint inhibitors (ICI) and chimeric antigen receptor (CAR) T cell therapy, has changed the landscape of treatment for patients with a variety of malignancies who historically had a poor prognosis.… read more here.
Keywords: car cell; risk; contemporary anticancer; treatment ... See more keywords